Stay updated on Dapagliflozin-Induced Liver Injury Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.

Latest updates to the Dapagliflozin-Induced Liver Injury Clinical Trial page
- Check3 days agoChange DetectedThe page now shows that the study is no longer recruiting participants, clarifying enrollment status. New help sections such as 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study' were added to guide users.SummaryDifference0.5%

- Check11 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, replacing the previous version label. This reflects an updated revision of the page's metadata rather than a change to the study content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision was bumped from v3.5.3 to v3.5.4. This indicates an updated version of the page, likely for backend or layout adjustments rather than changes to study content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page’s footer revision/version display has been updated from v3.5.2 to v3.5.3, indicating a platform software update rather than a change to the trial study details.SummaryDifference0.1%

- Check61 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check90 days agoChange DetectedSoftware version bump: v3.4.3 → v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin-Induced Liver Injury Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.